BioSpace.com News

Genentech and Biogen Idec, Inc. (Massachusetts) Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case

Fri, 17 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Copenhagen, Denmark; May 17, 2013 Genmab A/S (OMX: GEN) announced today that Genentech and Biogen Idec have filed for a re-hearing en banc (i.e. before all judges of the court) in the appeal case, where the...

The Ranbaxy Laboratories Whistleblower and the Scheme to Fool the FDA

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Earlier this week, the feds finally reached closure with Ranbaxy Laboratories with a $500 million deal to settle criminal and civil charges for a serious and widespread manufacturing ruse. The generic drugmaker...

Johnson & Johnson Gets a Shot in the Arm From World Health Organization Over Vaccine Deaths

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Amid a torrent of product recalls and scandals, Johnson & Johnson may have finally caught at least one break. After the Vietnamese Ministry of Health temporarily suspended the use of its Quinvaxem childhood...

Emmaus Life Sciences Wins Sweeping Summary Judgment Victory in Suit Against AFH Holding & Advisory and Amir Heshmatpour

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TORRANCE, Calif., May 16, 2013 /PRNewswire/ -- Emmaus Life Sciences, Inc., a company dedicated to the discovery, development...

Ranbaxy Laboratories Pays $500 Million to Settle Long-Running Production Scandal

Tue, 14 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

More than a year after entering into a consent decree over a far-reaching manufacturing scandal, Ranbaxy Laboratories has agreed to pay $500 million to settle criminal and civil charges associated with the episode...

Sanofi (France) Fined $52 Million Over Plavix Smear Campaign in France

Tue, 14 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

File this under 'Why didn't they know any better?' Four years ago, Sanofi grew worried that a generic version of its best-selling Plavix bloodthinner would gain attention from physicians and pharmacies in France...

AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) Hit With Flurry of Class Action Lawsuits

Mon, 13 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Attention NASDAQ:AVEO Investors: Lawsuit Against AVEO Pharmaceuticals, Inc. Filed

San Diego, CA -- (SBWIRE) -- 05/13/2013 -- An investor in shares of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO...

Fired Exec Claims ReSearch Pharmaceutical Services (RPS), Inc. Violated Privacy Practices in Hiring

Mon, 13 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

A former executive at a contract research organization claims he was wrongfully fired last year after complaining about a computer system that was used to track the sexual orientation, religion and political...

Pfizer Inc. Exec Faces Adult Film Charges Which Include Children in Puerto Rico

Mon, 13 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Federal authorities in Puerto Rico have arrested an executive at Pfizer Pharmaceutical for allegedly producing child pornography. Officials say 48-year-old Reinaldo Diaz Camacho was charged after Puerto Rico...

Patent Litigation Settlement and License Between and W. L. Gore & Associates, Inc.

Mon, 13 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ELKTON, MD--(Marketwired - May 13, 2013) - EMD Millipore Corporation and W. L. Gore & Associates, Inc. announced today the settlement of patent infringement disputes between...

Will Male Breasts Derail a Johnson & Johnson Settlement Over Risperdal Marketing?

Fri, 10 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

A much-anticipated settlement of various federal government probes into Johnson & Johnson marketing of the Risperdal antipsychotic, as well as other medications, is being delayed over language the health care...

Gevo, Inc. Temporarily Dismisses GIFT(R) Lawsuit Because Butamax Does Not Have a Commercial Biobutanol Plant

Fri, 10 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ENGLEWOOD, Colo., May 10, 2013 (GLOBE NEWSWIRE) -- Gevo, Inc. (Nasdaq:GEVO) today announced that it has agreed to temporarily dismiss its lawsuit against Butamax Advanced Biofuels, LLC (Butamax) and E. I. du...

Actavis Confirms District Court Ruling in Generic Lialda® Patent Suit

Fri, 10 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PARSIPPANY, N.J., May 9, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) today confirmed that the United States District...

Former Johnson & Johnson Employee Sues Over Age Discrimination

Thu, 09 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

A former Johnson & Johnson employee has claimed in a lawsuit that she was fired because of her age and medical disability, and wrongly accused of fraud in maintaining company records. The former employee, Sylvia...

Sanford Heisler Files $100 Million+ Discrimination Suit Against Pharma Giant Merck & Co., Inc.

Thu, 09 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEWARK, N.J., May 9, 2013 /PRNewswire/ -- Sanford Heisler LLP today filed a $100 million individual and class action suit in the U.S. District...

Shire plc Wins Patent Trial Against Watson Pharmaceuticals, Inc. Concerning LIALDA®

Thu, 09 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PHILADELPHIA, May 9, 2013 /PRNewswire/

Shire plc (LSE: SHP, NASDAQ: SHPG), announces that its subsidiary, Shire Development LLC, has prevailed in its litigation against Watson Pharmaceuticals Inc...

Teva Pharmaceutical Industries Limited Regrets Firing Employee Who Developed a Brain Tumor

Tue, 07 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Teva Pharmaceuticals, one of the bulwarks of the Israeli economy, has decided not to fight a court ruling that, essentially, leaves the drugmaker looking insensitive heartless. A Tel Aviv District Labor Court...

Genentech Manager Sues Airline Over Toilet Fracas

Mon, 06 May 2013 12:00:00 AM GMT

A passenger who flew from Philadelphia to San Francisco was detained on arrival by federal agents after a vindictive flight attendant claimed he had not flushed a lavatory toilet, according to a federal suit. The suit, which seeks $500,000 in damages, was filed last week in the Northern District of California. Salvatore Bevivino, 52, a business manager for Genentech, boarded a Virgin America flight...

Judge Gives Onetime "King of Biotech" 4 Years in Prison

Mon, 06 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

A once prominent biotechnology investor was handed four years in prison on Thursday after pleading guilty to stock manipulation, the second time he has run afoul of U.S. securities laws. David Blech, ...

Precision BioSciences Wins Patent Infringement Lawsuit Against Cellectis

Mon, 06 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that it has won a patent infringement lawsuit against Cellectis...

Takeda Pharmaceutical Co. Ltd. Gets $6.5 Million Diabetes-Drug Verdict Thrown Out

Thu, 02 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DEERFIELD, Ill., May 1, 2013 -- /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc. announced today that in the case of Jack Cooper, et al. v. Takeda Pharmaceuticals America, Inc., et al., No. CGC-1...

BioIndustry Association Comment on European Medicines Agency Interim Ruling by EU General Court

Tue, 30 Apr 2013 12:00:00 AM GMT

30 April 2013 -- Commenting on the interim ruling of the General Court of the European Union preventing the European Medicines Agency (EMA) from providing documents as part of two access-to-documents requests until a final ruling is given by the Court, Steve Bates, BioIndustry Association (BIA) Chief Executive Officer, said:

"The interim ruling must not delay the timetable for introducing...

Uncle Sam Busts Novartis AG Again

Mon, 29 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

EAST HANOVER, N.J., April 26, 2013 /PRNewswire/ -- Novartis Pharmaceuticals Corporation (NPC) disputes the allegations made by the US Attorney's Office (USAO) for the...

Takeda Pharmaceuticals Loses Cancer Suit Over Actos

Mon, 29 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DEERFIELD, Ill., April 26, 2013 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc. announced today that in the case of

Actavis Announces OxyContin® Patent Challenge Settlement

Fri, 26 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PARSIPPANY, N.J., April 26, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT), a leading specialty pharmaceutical company...

Guilty Plea Expected in Fake Version of Roche's Avastin Case

Thu, 25 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

A salesman who marketed illegal cancer treatments in the U.S. for a Canadian company embroiled in a counterfeit-drug scandal is scheduled to plead guilty on Wednesday to a federal charge of covering up a...

U.S. Authorities Investigate AstraZeneca PLC's Macclesfield Base

Thu, 25 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Global pharmaceutical giant AstraZeneca said today (25 April 2013) it was helping authorities in America with an investigation into its plant in Macclesfield. The drugs group's base in the Cheshire town is...

U.S. Accuses Novartis AG of Providing Kickbacks

Wed, 24 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Tuesday, April 23, 2013 -- Suit Alleges Novartis Induced Pharmacies to Switch Thousands of Transplant Patients to One of Its Drugs with Kickbacks Disguised as Rebates and Discounts, Resulting in Medicare...

Ex-Aptuit LLC Employee Gets Jail Time for Manipulation of Trial Data

Mon, 22 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Late last week, a former employee of the Aptuit clinical research organization was sentenced to three months in jail for altering pre-clinical trial data that was used to support applications to perform...

Bayer AG Patent on Yaz Birth Control Pill Ruled Invalid

Thu, 18 Apr 2013 12:00:00 AM GMT

Bayer AG (BAYN)s patent on the birth control pill Yaz is invalid, a U.S. appeals court said in a decision that ensures Actavis Inc. (ACT) and Novartis AG (NOVN)s Sandoz unit can sell copies of the contraceptive. Actavis, Sandoz and Lupin Ltd. (LPC) won a ruling that the patent is invalid because its an obvious variation of earlier know- how, the U.S. Court of Appeals for the Federal Circuit in Washington...

Court Orders FDA to Suspend Approval of Bayer HealthCare Drug

Thu, 18 Apr 2013 12:00:00 AM GMT

Enroflox 100, a new generic drug formulated for the treatment of bovine respiratory disease, is on hold pending a legal challenge over the U.S. Food and Drug Administrations approval of the medication. The manufacturer, Norbrook Laboratories of Lenexa, Kan., received FDA approval March 29 of an Abbreviated New Animal Drug Application for Enroflox 100 (enrofloxacin), a generic version of Bayer HealthCare...

Amgen to Pay $25 Million to Settle Kickback Allegations

Wed, 17 Apr 2013 12:00:00 AM GMT

Amgen Inc has agreed to pay $24.9 million to settle allegations that it provided kickbacks to long-term care pharmacy providers to entice them to use its Aranesp anemia drug instead of a rival medicine, the Department of Justice announced on Tuesday. The DOJ charged that the world's largest biotechnology company violated the False Claims Act through kickbacks paid to Omnicare Inc, Kindred Healthcare...

Actavis Confirms Favorable Ruling in Generic Yaz® Patent Suit

Wed, 17 Apr 2013 12:00:00 AM GMT

PARSIPPANY, N.J., April 16, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) today announced that it has re-launched Vestura (3 mg drospirenone and 0.02 mg ethinyl estradiol), a generic version of Bayer HealthCare Pharmaceuticals Inc.'s Yaz oral contraceptive product, following a ruling from

Takeda Pharmaceutical Co. Ltd.'s Actos Diabetes Drug Tied to Cancer, Jury is Told

Tue, 16 Apr 2013 12:00:00 AM GMT

Takeda Pharmaceutical Co. (4502), Asias biggest drugmaker, hid the cancer risks of its Actos drug to protect billions in sales, a jury was told in the first of more than 3,000 lawsuits over the diabetes medication to go to trial. While Takedas internal Actos studies uncovered links to bladder cancer as early as 2004, the company didnt alert U.S. regulators until seven years later, Michael Miller...

Supreme Court Denies GlaxoSmithKline Appeal Over Avandia Suit

Tue, 16 Apr 2013 12:00:00 AM GMT

The U.S. Supreme Court Monday denied a request by drugmaker GlaxoSmithKline to hear its appeal of a decision by U.S. Court of Appeals for the Third Circuit, which allowed health insurance giant Humana to sue Glaxo over sales of Glaxo's controversial diabetes drug Avandia. The Third Circuit is based in Philadelphia and the original suit was filed there. Glaxo also has a huge presence in the city and...

Request to Appoint Tustee or Examiner in Biovest International, Inc. Case Denied

Tue, 16 Apr 2013 12:00:00 AM GMT

A Tampa bankruptcy judge has denied an equity committees motion to appoint a trustee or examiner in Biovest Internationals bankruptcy case. The committee contended that Tampa-based Biovest (OTCQB: BVTI) has admitted withholding information that may be related to the value of the business. As a basis for its request for a trustee or examiner appointment, the motion also alleged that recent information...

Bio-Reference Laboratories Responds to an Employee Wrongful Termination Suit Filed Against It as Baseless and Without Merit

Mon, 15 Apr 2013 12:00:00 AM GMT

ELMWOOD PARK, N.J., April 12, 2013 (GLOBE NEWSWIRE) -- Bio-Reference Laboratories, Inc. (BRLI) strongly denounced and denied the allegations of a complaint that has been filed against the Company in the Superior Court of New Jersey by an apparently disgruntled, former employee. The Company has indicated that it will vigorously defend this case, if it proceeds, and will seek to vindicate itself through...

Glenmark Pharmaceuticals to Respond to Patent Row With Merck & Co., Inc. Next Month

Mon, 15 Apr 2013 12:00:00 AM GMT

The Delhi High Court on Friday sought response of Glenmark Pharmaceuticals on US drug major Merck Sharp and Dohme's appeal against the single judge bench order refusing to restrain the Indian firm from manufacturing and selling anti-diabetes drugs Zita and Zita-Met. A bench of Justices S Ravindra Bhat and S K Mishra issued a notice to Glenmark and sought its reply by May 22 on the US firm's plea challenging...

Bayer AG Sues FDA Seeking to Block Sales of Generic Baytril

Thu, 11 Apr 2013 12:00:00 AM GMT

Bayer AG (BAYN) sued the U.S. Food and Drug Administration seeking to block sales of a generic form of the livestock antibiotic Baytril 100 being sold by competitor Norbrook Laboratories Ltd. Bayer, in a complaint filed today in Washington, said the FDAs approval of Norbrooks Enroflox 100 product to treat bovine respiratory disease was unlawful because the agency hadnt responded to Bayers concerns...

Eli Lilly and Company Settles Wrongful Death Lawsuit

Wed, 10 Apr 2013 12:00:00 AM GMT

Eli Lilly and Co. has settled a long-running wrongful death lawsuit filed by the parents of a South Dakota boy who committed suicide on Christmas Eve 2004, four weeks after taking the antidepressant Cymbalta. The settlement comes a month before a jury trial was set to begin in a South Dakota federal court. Terms werent disclosed in court filings. An order filed last week by a magistrate judge said...

Warner Chilcott, PLC Sued Over Loestrin Pay-for-Delay Deals

Wed, 10 Apr 2013 12:00:00 AM GMT

Warner Chilcott PLC was hit with a class action on Friday alleging the drugmaker violated U.S. antitrust laws when it agreed to settle "sham" patent infringement litigation against Lupin Pharmaceuticals Inc. and Watson Pharmaceuticals Inc. that delayed entry of generic versions of oral contraceptive Loestrin.

Merck & Co., Inc. Starts a New Trial Over Fosamax Damage

Mon, 08 Apr 2013 12:00:00 AM GMT

Merck & Co. (MRK) is fighting a womans claim that its osteoporosis drug Fosamax weakened her femur, causing her leg to break when she fell in her driveway, less than a month after the first such trial ended prematurely. A three-week jury trial starting today before U.S. District Judge Joel Pisano in Trenton, New Jersey, will involve medical experts on both sides of the dispute over the cause of Bernadette...

Delhi High Court Refuses Interim Relief to U.S. Drug Firm Merck & Co., Inc.

Fri, 05 Apr 2013 12:00:00 AM GMT

The Delhi High Court today refused to grant interim relief on a patent row to US pharmaceuticals major Merck Sharp and Dohme (MSD) which sought a restraint on Indian firm Glenmark PharmaceuticalsBSE -0.07 % on manufacturing and marketing anti-diabetes drugs Zita and Zita-Met. Justice Rajiv Sahai Endlaw dismissed the interim application of the multinational pharma major that the Mumbai-based firm be...

Court Upholds $142 Million Verdict Against Pfizer Inc. Over Neurontin

Thu, 04 Apr 2013 12:00:00 AM GMT

A federal appeals court said Pfizer Inc should pay about $142 million to cover costs for the marketing and prescribing of epilepsy drug Neurontin for unapproved uses, a practice that has also earned it a hefty criminal fine. A panel of appellate judges in Boston on Wednesday refused to overturn a ruling in favor of Kaiser Foundation Health Plan, which claimed it had been damaged after prescribing Neurontin...

AstraZeneca PLC Wins Temporary Block on Actavis Asthma Drug

Thu, 04 Apr 2013 12:00:00 AM GMT

April 04, 2013 -- Actavis Inc. (>> Actavis Inc) confirmed a New Jersey court has granted a motion from AstraZeneca PLC (>> AstraZeneca plc) seeking a temporary restraining order to prevent Actavis from further distributing its generic version of asthma treatment Pulmicort Respules.

The ruling follows the Monday launch of Actavis's product after the court found that Actavis's 0.25, 0.5 and...

Merck & Co., Inc. Unit Sues Glenmark Pharmaceuticals for Infringing Patent on Diabetes Drugs

Wed, 03 Apr 2013 12:00:00 AM GMT

US-based MSD Pharma, the third-largest pharma company in the world by revenues, has asked the Delhi High Court to bar Mumbai-based Glenmark from selling two popular anti-diabetic drugs, triggering yet another legal battle between an Indian generic company and a member of Big Pharma. MSD's move comes a week after Glenmark Pharma launched generic versions of a range of anti-diabetes products sold by...

Actavis Confirms Court Issues TRO Related to Generic Pulmicort RESPULES® Distribution

Wed, 03 Apr 2013 12:00:00 AM GMT

PARSIPPANY, N.J., April 3, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) today confirmed that the United States District Court for the District of New Jersey has granted a motion by AstraZeneca seeking a temporary restraining order (TRO) to prevent Actavis from further distribution...

Eli Lilly and Company Insurer's Lawsuit Says Insider Information Led to $60 Million Drug Heist

Tue, 02 Apr 2013 12:00:00 AM GMT

So artfully done was the overnight theft of more than $60 million worth of drugs from an Eli Lilly and Co. warehouse in Connecticut that it seemed an inside job. It essentially was, contends a lawsuit filed last month by the company that insured the Lilly building. The brazen March 2010 break-in was made possible, the lawsuit says, because thieves got their hands on a proprietary report, done for Lilly...

Actavis Confirms Favorable Ruling in Generic Pulmicort RESPULES® Patent Suit

Tue, 02 Apr 2013 12:00:00 AM GMT

PARSIPPANY, N.J., April 1, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) today confirmed that the United States District Court for the District of New Jersey has ruled that Actavis' generic version of AstraZeneca's Pulmicort RESPULES (budesonide inhalation suspension...

Novartis AG Loses Cancer Drug Glivec Patent Case

Mon, 01 Apr 2013 12:00:00 AM GMT

India's top court dismissed Swiss drugmaker Novartis AG's attempt to win patent protection for its cancer drug Glivec, a blow to Western pharmaceutical firms targeting India to drive sales and a victory for local makers of cheap generics. The decision sets a benchmark for intellectual property cases in India, where many patented drugs are unaffordable for most of its 1.2 billion people, and does not...

Actavis Confirms Generic AndroGel® 1.62% Patent Challenge

Mon, 01 Apr 2013 12:00:00 AM GMT

PARSIPPANY, N.J., April 1, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Testosterone Gel, 1.62%. Actavis' ANDA product is a generic version of AbbVie Inc...

Pfizer Inc. Fails to End Lawsuit Over Bextra, Celebrex Safety

Fri, 29 Mar 2013 12:00:00 AM GMT

Pfizer Inc has failed to persuade a federal judge to dismiss a shareholder lawsuit accusing the company of fraudulently misrepresenting the safety of its Celebrex and Bextra pain-relieving drugs. While dismissing some of the claims, U.S. District Judge Laura Taylor Swain in Manhattan said a reasonable jury could find that Pfizer and several top executives intended to mislead shareholders about the...

Novo Nordisk A/S Lures Sanofi (France) Pitchman as Diabetes Battle Heats Up

Thu, 28 Mar 2013 12:00:00 AM GMT

As a former professional cyclist, Phil Southerland knows about competition. So when Southerland, a diabetic whose team was funded by drugmaker Sanofi (SAN) for six years, wanted a better sponsorship deal, he knew who to contact: archrival Novo Nordisk A/S (NOVOB). Novo was quick to snap him up, offering a contract worth several million dollars, according to people familiar with the negotiations. The...

Pfizer Inc. Settles Rimadyl Lawsuit and a Dead Dog

Wed, 27 Mar 2013 12:00:00 AM GMT

Two years after filing a widely publicized lawsuit, a Colorado couple has reached a settlement with Pfizer over allegations the drugmaker failed to sufficiently warn that its Rimadyl medication, a non-steroidal anti-inflammatory treatment for dogs, can cause severe harm. And now, the couple plans to take the proceeds to start a campaign to raise awareness about what they say are the dangers of the...

Star Scientific , Inc. Responds to Plaintiff's Purported Class Action Lawsuit

Wed, 27 Mar 2013 12:00:00 AM GMT

GLEN ALLEN, Va., March 26, 2013 /PRNewswire/ -- Paul L. Perito, Esquire, Chairman, President, and COO of Star Scientific, Inc. (NASDAQ: STSI), issued the following statement on behalf of Star Scientific and Rock Creek Pharmaceuticals, Inc.:

This morning, Star...

W. R. Grace & Company Files Flash Chromatography Patent Infringement Suit Against

Wed, 27 Mar 2013 12:00:00 AM GMT

Columbia, MD March 25, 2013 On March 15, 2013, W. R. Grace & Co. (NYSE: GRA), through its wholly-owned subsidiary, Alltech Associates, Inc., filed a lawsuit in U.S. District Court for the District of Delaware against Teledyne Technologies, Inc., doing business as Teledyne Isco of Lincoln, Neb., for infringement of four Grace U.S. Patents that cover its proprietary Reveleris X2 flash...

InSite Vision Wins Appeal of Patent Interference Litigation Against the University of California, San Francisco (UCSF)

Tue, 26 Mar 2013 12:00:00 AM GMT

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB: INSV) today announced that the U.S. Court of Appeals for the Federal Circuit affirmed by a split decision the ruling of the United States Patent and Trademark Office (USPTO) panel of judges which found in favor of the Company in its patent interference litigation with the University of California, San Francisco (UCSF), and confirmed...

AstraZeneca PLC Settles Crestor Patent Case With Actavis

Mon, 25 Mar 2013 12:00:00 AM GMT

PARSIPPANY, N.J., March 25, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT), a leading specialty pharmaceutical company, today announced that is has reached a settlement agreement with AstraZeneca resolving outstanding patent litigation related to Actavis' generic version of rosuvastatin calcium 5, 10, 20 and 40 mg tablets, the generic version of Crestor^<...

Johnson & Johnson Argues No One in SC Was Harmed in $327 Million Case